Skip to main content
icon for Flu Hospitalization Rate Week 23, 2026?

Flu Hospitalization Rate Week 23, 2026?

icon for Flu Hospitalization Rate Week 23, 2026?

Flu Hospitalization Rate Week 23, 2026?

jun 19

jun 19

85–90 93.8%

90–95 3.7%

<80 <1%

95–100 <1%

Polymarket
NUEVO

85–90 93.8%

90–95 3.7%

<80 <1%

95–100 <1%

Polymarket
NUEVO

<80

$397 Vol.

1%

80–85

$397 Vol.

<1%

85–90

$3,036 Vol.

94%

90–95

$143 Vol.

4%

95–100

$245 Vol.

1%

100+

$455 Vol.

<1%

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The dominant market consensus around an 85–90 cumulative FluSurv-NET hospitalization rate for Week 23, 2026 (ending June 13) reflects the season’s already elevated burden, with the cumulative rate reaching 87.5 per 100,000 by Week 22 amid a notably severe 2025–2026 outbreak driven primarily by influenza A(H3N2). Late-season weekly rates have fallen to 0.1 per 100,000, consistent with historical off-season patterns and CDC forecasts projecting only 320–2,000 additional national admissions through mid-June. This positions the final cumulative figure firmly within the 85–90 band absent major reporting revisions. A realistic challenge would require an anomalous late-June surge or substantial upward data adjustments, both improbable given sustained low transmission and surveillance trends.

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.

If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.

The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.

Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volumen
$4,674
Fecha de finalización
19 jun 2026
Mercado abierto
Jun 12, 2026, 7:22 PM ET

Resolver

0x69c47De9D...
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The dominant market consensus around an 85–90 cumulative FluSurv-NET hospitalization rate for Week 23, 2026 (ending June 13) reflects the season’s already elevated burden, with the cumulative rate reaching 87.5 per 100,000 by Week 22 amid a notably severe 2025–2026 outbreak driven primarily by influenza A(H3N2). Late-season weekly rates have fallen to 0.1 per 100,000, consistent with historical off-season patterns and CDC forecasts projecting only 320–2,000 additional national admissions through mid-June. This positions the final cumulative figure firmly within the 85–90 band absent major reporting revisions. A realistic challenge would require an anomalous late-June surge or substantial upward data adjustments, both improbable given sustained low transmission and surveillance trends.

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.

If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.

The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.

Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volumen
$4,674
Fecha de finalización
19 jun 2026
Mercado abierto
Jun 12, 2026, 7:22 PM ET

Resolver

0x69c47De9D...
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.

Cuidado con los enlaces externos.

Preguntas frecuentes

"Flu Hospitalization Rate Week 23, 2026?" es un mercado de predicción en Polymarket con 6 resultados posibles donde los operadores compran y venden acciones según lo que creen que sucederá. El resultado líder actual es "85–90" con 94%, seguido de "90–95" con 4%. Los precios reflejan probabilidades en tiempo real de la comunidad. Por ejemplo, una acción cotizada a 94¢ implica que el mercado colectivamente asigna una probabilidad de 94% a ese resultado. Estas probabilidades cambian continuamente a medida que los operadores reaccionan a nuevos desarrollos. Las acciones del resultado correcto son canjeables por $1 cada una tras la resolución del mercado.

"Flu Hospitalization Rate Week 23, 2026?" es un mercado recién creado en Polymarket, lanzado el Jun 13, 2026. Como mercado nuevo, esta es tu oportunidad de ser uno de los primeros operadores en establecer las probabilidades y las señales de precio iniciales del mercado. También puedes guardar esta página en marcadores para seguir el volumen y la actividad de trading a medida que el mercado gana tracción.

Para operar en "Flu Hospitalization Rate Week 23, 2026?", explora los 6 resultados disponibles en esta página. Cada resultado muestra un precio actual que representa la probabilidad implícita del mercado. Para tomar una posición, selecciona el resultado que consideres más probable, elige "Sí" para operar a favor o "No" para operar en contra, introduce tu cantidad y haz clic en "Operar". Si tu resultado elegido es correcto cuando el mercado se resuelve, tus acciones de "Sí" pagan $1 cada una. Si es incorrecto, pagan $0. También puedes vender tus acciones en cualquier momento antes de la resolución.

El favorito actual para "Flu Hospitalization Rate Week 23, 2026?" es "85–90" con 94%, lo que significa que el mercado asigna una probabilidad de 94% a ese resultado. El siguiente resultado más cercano es "90–95" con 4%. Estas probabilidades se actualizan en tiempo real a medida que los operadores compran y venden acciones. Vuelve con frecuencia o guarda esta página en marcadores.

Las reglas de resolución para "Flu Hospitalization Rate Week 23, 2026?" definen exactamente qué debe ocurrir para que cada resultado sea declarado ganador, incluyendo las fuentes de datos oficiales utilizadas para determinar el resultado. Puedes revisar los criterios de resolución completos en la sección "Reglas" en esta página sobre los comentarios. Recomendamos leer las reglas cuidadosamente antes de operar, ya que especifican las condiciones exactas, casos especiales y fuentes.